Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification

PURPOSE: While HER2 testing is well established in directing appropriate treatment for breast cancer, a small percentage of cases show equivocal results by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). Alternative probes may be used in equivocal cases. We present a single...

Descripción completa

Detalles Bibliográficos
Autores principales: Agersborg, Sally, Mixon, Christopher, Nguyen, Thanh, Aithal, Sramila, Sudarsanam, Sucha, Blocker, Forrest, Weiss, Lawrence, Gasparini, Robert, Jiang, Shiping, Chen, Wayne, Hess, Gregory, Albitar, Maher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999182/
https://www.ncbi.nlm.nih.gov/pubmed/29564742
http://dx.doi.org/10.1007/s10549-018-4755-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999182/
https://www.ncbi.nlm.nih.gov/pubmed/29564742
http://dx.doi.org/10.1007/s10549-018-4755-5

Ejemplares similares